Publications

Detailed Information

Enhanced interleukin-2 diphtheria toxin conjugate-induced growth suppression in retinoic acid-treated hypoxic hepatocellular carcinoma cells

DC Field Value Language
dc.contributor.authorKim, Bo Hyun-
dc.contributor.authorYoon, Jung-Hwan-
dc.contributor.authorMyung, Sun Jung-
dc.contributor.authorLee, Jeong-Hoon-
dc.contributor.authorLee, Soo-Mi-
dc.contributor.authorLee, Hyo-Suk-
dc.contributor.authorLee, Sung-Hee-
dc.date.accessioned2012-05-24T00:33:29Z-
dc.date.available2012-05-24T00:33:29Z-
dc.date.issued2009-02-18-
dc.identifier.citationCANCER LETTERS; Vol.274 2; 259-265ko_KR
dc.identifier.issn0304-3835-
dc.identifier.urihttps://hdl.handle.net/10371/76363-
dc.description.abstractHypoxia induces survival signals in hepatocellular carcinoma (HCC). Hypoxia and retinoic acid (RA) may also induce interleukin-2 (IL-2) receptor expression, and thus we evaluated if RA and IL-2 receptor-targeted therapy are indicated in hypoxic HCCs. RA induced IL-2 receptor expression (R alpha, R beta, R gamma) in HCC cells, whereas hypoxia specifically induced IL-2 R gamma expression. IL-2 stimulated hypoxic HCC cell growth via p42/44 MAPK activation. Combination of denileukin diftitox and RA significantly suppressed hypoxic HCC cell growth compared to single agent-treated or normoxic cells. Therefore, denileukin diftitox and RA may be therapeutically implicated in infiltrative HCCs which are exposed to hypoxic environments. (C) 2008 Elsevier Ireland Ltd. All rights reserved.ko_KR
dc.description.sponsorshipThis study was supported by the Seoul National
University Hospital Research Fund (#03-2006-019) and the Korea Health
21 R&D Project (#0412-CR01-0704-0001).
ko_KR
dc.language.isoenko_KR
dc.publisherELSEVIER IRELAND LTDko_KR
dc.subjectHypoxiako_KR
dc.subjectRetinoic acidko_KR
dc.subjectInterleukin-2ko_KR
dc.subjectInterleukin-2 diphteria toxin conjugateko_KR
dc.subjectHepatocellular carcinomako_KR
dc.titleEnhanced interleukin-2 diphtheria toxin conjugate-induced growth suppression in retinoic acid-treated hypoxic hepatocellular carcinoma cellsko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor김보현-
dc.contributor.AlternativeAuthor윤정환-
dc.contributor.AlternativeAuthor명선정-
dc.contributor.AlternativeAuthor이정훈-
dc.contributor.AlternativeAuthor이성희-
dc.contributor.AlternativeAuthor이수미-
dc.contributor.AlternativeAuthor이효석-
dc.identifier.doi10.1016/j.canlet.2008.09.025-
dc.citation.journaltitleCANCER LETTERS-
dc.description.citedreferenceKarmakar S, 2007, APOPTOSIS, V12, P2077, DOI 10.1007/s10495-007-0116-2-
dc.description.citedreferencePastan I, 2007, ANNU REV MED, V58, P221, DOI 10.1146/annurev.med.58.070605.115320-
dc.description.citedreferencePang RWC, 2007, ONCOLOGY-BASEL, V72, P30, DOI 10.1159/000111705-
dc.description.citedreferenceFoss F, 2006, SEMIN ONCOL, V33, pS11, DOI 10.1053/j.seminoncol.2005.12.017-
dc.description.citedreferenceArce F, 2005, CANCER LETT, V229, P271, DOI 10.1016/j.canlet.2005.06.047-
dc.description.citedreferenceFoss F, 2005, BLOOD, V106, P454, DOI 10.1182/blood-2004-11-4570-
dc.description.citedreferenceEl-Metwally TH, 2005, CANCER BIOL THER, V4, P474-
dc.description.citedreferenceGwak GY, 2005, J HEPATOL, V42, P358, DOI 10.1016/j.jhep.2004.11.020-
dc.description.citedreferenceShimizu M, 2004, CLIN CANCER RES, V10, P6710-
dc.description.citedreferenceSimeone AM, 2004, CELL MOL LIFE SCI, V61, P1475, DOI 10.1007/s00018-004-4002-6-
dc.description.citedreferenceGarcia-Tunon I, 2004, BREAST CANCER RES, V6, pR1, DOI 10.1186/bcr730-
dc.description.citedreferenceDupuy E, 2003, J HEPATOL, V38, P793, DOI 10.1016/S0168-8278(03)00086-2-
dc.description.citedreferenceGorgun G, 2002, BLOOD, V100, P1399, DOI 10.1182/blood-2002-01-0300-
dc.description.citedreferenceHerold C, 2002, INT J ONCOL, V20, P89-
dc.description.citedreferenceSeki T, 2001, EUR J GASTROEN HEPAT, V13, P291-
dc.description.citedreferenceRoyuela M, 2000, GROWTH FACTORS, V18, P135-
dc.description.citedreferenceCarswell KS, 2000, CYTOTHERAPY, V2, P25-
dc.description.citedreferenceKobayashi N, 1999, LIVER, V19, P25-
dc.description.citedreferenceSidell N, 1997, CELL IMMUNOL, V179, P116-
dc.description.citedreferenceRe GG, 1996, CANCER RES, V56, P2590-
dc.description.citedreferencePARK JG, 1995, INT J CANCER, V62, P276-
dc.description.citedreferencePLAISANCE S, 1993, INT J CANCER, V55, P164-
dc.description.citedreferenceWEIDMANN E, 1992, CANCER RES, V52, P5963-
dc.description.citedreferenceHUANG CC, 1992, J NATL CANCER I, V84, P262-
dc.description.citedreferenceSMITH KA, 1984, ANNU REV IMMUNOL, V2, P319-
dc.description.citedreferenceNAKABAYASHI H, 1982, CANCER RES, V42, P3858-
dc.description.citedreferenceKNOWLES BB, 1980, SCIENCE, V209, P497-
dc.description.tc1-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share